Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus
- PMID: 2296623
- DOI: 10.1007/BF02245806
Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus
Abstract
1-(3-Chlorophenyl) piperazine (mCPP) was previously shown to have an anxiogenic-like effect, i.e., it decreased total interaction in a rat social interaction test. Evidence indicated mediation by activation of 5-HT1C receptors with an ED50 of approximately 500 micrograms/kg IP (Kennett et al. 1989). A comparable effect is now shown on infusing 4 micrograms of the drug ICV or infusing 0.5 microgram into the hippocampus. Both responses were dose dependent. Infusion of 1 microgram mCPP into the amygdala had no effect. None of the above treatments significantly reduced locomotion. Results are consistent with the postulated role of the hippocampus in anxiety.
Similar articles
-
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.Br J Pharmacol. 1988 May;94(1):137-47. doi: 10.1111/j.1476-5381.1988.tb11508.x. Br J Pharmacol. 1988. PMID: 3401632 Free PMC article.
-
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.Eur J Pharmacol. 1989 May 30;164(3):445-54. doi: 10.1016/0014-2999(89)90252-5. Eur J Pharmacol. 1989. PMID: 2767117
-
Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.Psychopharmacology (Berl). 1993;113(2):262-8. doi: 10.1007/BF02245708. Psychopharmacology (Berl). 1993. PMID: 7855192
-
Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.Life Sci. 2003 Aug 1;73(11):1347-67. doi: 10.1016/s0024-3205(03)00422-3. Life Sci. 2003. PMID: 12850497 Review.
-
m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors.Trends Pharmacol Sci. 1990 May;11(5):181-2. doi: 10.1016/0165-6147(90)90109-l. Trends Pharmacol Sci. 1990. PMID: 2188399 Review. No abstract available.
Cited by
-
Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.Psychopharmacology (Berl). 1995 Mar;118(2):178-82. doi: 10.1007/BF02245837. Psychopharmacology (Berl). 1995. PMID: 7617805
-
5HT drugs in animal models of anxiety.Psychopharmacology (Berl). 1993;112(1):13-20. doi: 10.1007/BF02247358. Psychopharmacology (Berl). 1993. PMID: 7871002 Review.
-
Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry.Neurochem Res. 1993 Jul;18(7):787-93. doi: 10.1007/BF00966774. Neurochem Res. 1993. PMID: 8103578
-
Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.Psychopharmacology (Berl). 1994 Feb;114(1):90-6. doi: 10.1007/BF02245448. Psychopharmacology (Berl). 1994. PMID: 7846211
-
In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.Br J Pharmacol. 1994 Mar;111(3):797-802. doi: 10.1111/j.1476-5381.1994.tb14808.x. Br J Pharmacol. 1994. PMID: 7912626 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical